Abstract
α-Synuclein has been implicated in the development of neural plaques in Parkinson’s Disease and Lewy-Body Dementia. This paper reports on the structural phase change behavior exhibited over a relevant range of temperatures in canonical protein Monte Carlo simulations for wild-type α-synuclein and three of its familial variants. We performed and analyzed these simulations to determine residue occupancy variations above and below this phase transition. From this analysis, we found regions above the phase transition temperature that consistently exhibited increased propensity for formation of long-chain beta-sheets, suggesting a possible role in α-synuclein aggregation.
Similar content being viewed by others
References
Allison JR, Varnai P, Dobson CM, Vendruscolo M (2009) Determination of the free energy landscape of ɑ-synuclein using spin label nuclear magnetic resonance measurements. J Am Chem Soc 131:18314–18326
Balesh DR, Ramjan Z, Floriano WB (2011) Unfolded annealing molecular dynamics conformers for wild-type and disease-associated variatns of alpha-synuclein show no propensity for beta-sheet formation. J Biophys Chem 2:123–133
Bermel WB, Bertini I, Felli I, Lee YM, Luchinat C, Kozminski W, Piai A, Pierattelli R, Stanek J, Zawadzka-Kazimierczuk A (2006) Protonless NMR experiments for sequence-specific assignment of backbone nuclei in unfolded proteins. J Am Chem Soc 128:3918–3919
Bertoncini CW, Fernandez C, Griesinger C, Jovin TM, Zwecksetter M (2005) Familial mutants of α-Synuclein with increased neurotoxicity have a destabilized conformation. J Biol Chem 280:30649–30652
Binolfi A, Rasia RM, Bertoncini CM, Ceolin M, Zweckstetter M, Griesinger C, Jovin TM, Fernandez CO (2006) Interaction of ɑ-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. J Am Chem Soc 128:9893–9901
Breydo LW, Wu J, Uversky VN (2012) α-synuclein misfolding and Parkinson’s disease. Biochim Biophys Acta 1822:261–285
Bussel R Jr, Eliezer D (2001) Residual structure and dynamics in Parkinson’s disease-associated mutants of ɑ-synuclein. J Biol Chem 276:45996–46003
Camilloni CV, Vendruscolo M (2013) A Relationship between the aggregation rates of α-synuclein variants and the β-Sheet populations in their monomeric forms. J Phys Chem B 117:10737–10741
Case DA, Darden T, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg A, Seabra G, Swails J, Goetz AW, Kolossváry I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh M-J, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, and Kollman PA (2012) Amber 12. Reference manual, University of California, San Francisco
Chen M, Margittai M, Jeannie C, Langen R (2007) Investigation of α-synuclein fibril structure by site-directed spin labelling. J Biol Chem 282:24970–24979
Cho MK, Nodet G, Kim H-Y, Jensen MR, Bernado P, Fernandez CO, Becker S, Blackledge M, Zweckstetter M (2009) Structural characterization of ɑ-synuclein in an aggregation prone state. Protein Sci 18:1840–1846
Choi W, Zibaee S, Jakes R, Serpell LC, Daveletov B, Crowther RA, Goedert M (2004) Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett 576:363–368
Clayton DF, George JM (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21:249–254
Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318–1320
Conway KA, Harper JD, Lansbury PT (2000) Fibrils formed in vitro from ɑ-synuclein and two mutant forms linked to Parkinson’s disease are typical amyloid. Biochemistry 39:2552–2563
Dedmon MM, Kresten LL, Christodoulou J, Vendruscolo M, Dobson CM (2005) Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc 127:476–477
Diao J, Burré J, Vivona S, Cipriano DJ, Sharma M, Kyoung M, Sudhof TC, Brunger AT (2013) Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. eLife 2:e000592. doi:10.7554/eLife.00592
Eaton JW, Bateman D, Hauberg S (2009) (GNU Octave) version 3.0.1 manual: a high-level interactive language for numerical computations. CreateSpace Independent Publishing Platform
Eaton JW, Bateman D, Hauberg S, Wehbring R (2014) GNUT Octave version 3.8.1 manual: a high-level interactive language for numerical computations. CreateSpace Independent Publishing Platform. ISBN: 1441413006. http://www.gnu.org/software/octave/doc/interpreter
Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Wenger RK, Yao H, Markley JL (2008) BioMagResBank. Nucleic Acids Res 36:D402–D408
Ferreon ACM, Moran CR, Ferreon JC, Deniz AA (2010) Alteration of the α-synuclein folding landscape by a mutation related to Parkinson’s disease. Ang Chem Int Edition 49:3469–3472
Fredenburg RA, Rospigliosi C, Meray RK, Kessler JC, Lashuel HA, Eliezer D, Lansbury PT Jr (2007) The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Biochemistry 46:7107–7118
Fusco G, Simone De A, Gopinath T, Vostrikov V, Vendruscolo M, Dobson CM, Veglia G (2014) Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nature Commun 5. doi:10.1038/ncomms4827
National Library of Medicine (US) (2015) Genetics home reference [Internet]. Cystic fibrosis. The Library, Bethesda, MD. http://ghr.nlm.nih.gov/gene/SNCA
Greenbaum EA, Graves C, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, Axelsen PH, Giasson BI (2005) The E46K mutation in α-synuclein increases amyloid fibril formation. J Biol Chem 2800:7800–7807
Han B, Liu Y, Ginzinger SW, Wishart DS (2011) SHIFTX2: significantly improved protein chemical shift prediction. J Biomol NMR. doi:10.1007/s10858-011-9478-4
Heise H, Hoyer W, Becker S, Andronesi OC, Riedal D, Baldus M (2005) Molecular-level secondary structure, polymorphism, and dynamics of full-length ɑ-synuclein fibrils studied by solid-state NMR. Proceeding of the national academy of sciences of the United States of America 102:15871–15876
Heise H, Celej M, Becker S, Riedel D, Pelah A, Kumar A, Jovin TM, Baldus M (2008) Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant ɑ-synuclein. J Mol Biol 380:444–450
Humphrey W, Dalke, A, Schulten K (1996) VMD—visual molecular dynamics. J Mol Graph 14:33–38
Irbäck A, Mohanty S (2006) PROFASI: a Monte Carlo simulation package for protein folding and aggregation. J Comput Chem 27:1548–1555
Jensen PH, Nielsen M, Jakes R, Dotti CG, Goedert M (1998) Binding of α-Synuclein to brain vesicles is abolished by familial Parkinson’s disease mutation. J Biol Chem 273:26292–26294
Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE (2002) Defective membrane interactions of familial Parkinson’s disease mutant A30P ɑ-synuclein. J Mol Biol 315:799–807
Jónsson SA, Mohanty S, Irbäck A (2012) Distinct phase of free α-synuclein—a Monte Carlo study. Proteins 80:2169–2177
Kim H-Y, Heise H, Fernandez CO, Baldus M, Zweckstetter M (2007) Correlation of amylioid fibril B-structure with the unfolded state of α-Synuclein. Chem BioChem 8:1671–1674
Lee HJ, Bae E, Lee SJ (2014) Extracellular α-synuclein-a novel and crucial factor in Lewy body diseases. Nat Rev 10:92–98
Lemkau LR, Comellas G, Kloepper KD, Woods WS, George JM, Rienstra CM (2012) Mutant Protein A30P α-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. J Biol Chem 287:11526–11532
Lemkau LR, Comellas G, Lee SW, Rikardsen LK, Woods WS, George JM, Rienstra CM (2013) Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson’s Disease Associated Mutations A53T and E46K. PLoS ONE 8:e49750
Lendel C, Damberg P (2009) 3D J-resolved NMR spectroscopy for unstructured polypeptides: fast measurement of ^{3}J_{HNHα} coupling constants with outstanding spectral resolution. J Biomol NMR 44:35–42
Li J, Uversky V, Fink AL (2001) Effect of familial Parkinson’s disease Point mutations A30P and A53T on the structural properties aggregation, and fibrillation of human α-Synuclein. Biochemistry 40:11604–11613
Mitternacht SS, Staneva I, Hard T, Irback A (2010) Comparing the folding free-energy landscapes of AB42 variants with different aggregation properties. Proteins 78:2600–2608
Narhi L, Wood S, Steavenson S, Jian Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypch J, Biere AL, Citron M (1999) Both familial Parkinson’s disease mutations accelerate ɑ-synuclein aggregation. J Boil Chem 274:9843–9846
Neal S, Nip AM, Zhang H, Wishart DS (2003) Rapid and accurate calculation of protein 1H, 13C, and 15 N chemical shifts. J Biomol NMR 26:215–240
Neupane K, Solanki A, Sosova I, Belov M, Woodside MT (2014) Diverse metastable structures formed by small oligomers of α-synuclein probed by force spectroscopy. PLoS ONE 9:e86495. doi:10.1371/journal.pone.0086495
Ortega A, Amorós D, de la Torre JG (2011) Prediction of hydrodynamic and other solution properties of rigid proteins from atomic- and residue-level models. Biophys J 101:892–898
Pawar AP, Dubay K, Zurdo J, Chiti F, Vendruscolo M, Dobson CM (2005) Prediction of “aggregation-prone” and “aggregation-susceptible” regions in proteins associated with neurodegenerative diseases. J Mol Boil 350:379–392
Schmidt JM, Blümel M, Löhr F, Rüterjans H (1999) Self-consistent 3 J coupling analysis for the joint calibration of Karplus coefficients and evaluation of torsion angles. J Biomol NMR 14:1–12
Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA (2000) Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proceeding of the National Academy of Sciences of the United States of America 97:4897–4902
Vilar M, Chou HT, Luhrs T, Maji SK, Riek-Loher D, Verel R, Manning G, Stahlberg H, Riek R (2008) The fold of α-synuclein fibrils. Proceeding of the National Academy of Sciences of the United States of America 105: 8637–8642
Wise-Scira O, Aloglu A, Dunn A, Sakallioglu IT, Coskuner O (2013) Structures and free energy landscapes of the wild-type and A30P mutant-type alpha-Synuclein proteins with dynamics. ACS Chem Neurosci 4:486–497
Wu K-P, Weinstock D, Narayanan C, Levy RM, Baum J (2009) Structural reorganization of ɑ-Synuclein at low pH observed by NMR and REMD simulations. J Mol Biol 391:784–796
Acknowledgments
This research was supported by a grant from Alberta Innovates Health Solutions under the CRIO program. J. A. T acknowledges funding from NSERC (Canada).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Healey, M.A., Woodside, M.T. & Tuszynski, J.A. Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein. Eur Biophys J 45, 355–364 (2016). https://doi.org/10.1007/s00249-015-1103-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00249-015-1103-0